Tun bayan barkewar cutar ta COVID-19, mutane da yawa ba su fahimci hanyoyin ganowa daban-daban ba, gami da gano acid nucleic, gano maganin rigakafi, da gano antigen.Wannan labarin ya fi kwatanta waɗannan hanyoyin ganowa.
Gano acid nucleic a halin yanzu shine "ma'aunin zinare" don gano sabon coronavirus kuma a halin yanzu shine babbar hanyar gwaji a China.Gano acid nucleic yana da manyan buƙatu don kayan aikin ganowa, tsabtar dakin gwaje-gwaje da masu aiki, kuma kayan aikin PCR masu ƙarfi suna da tsada, kuma lokacin ganowa yana da ɗan tsayi.Sabili da haka, ko da yake hanya ce don ganewar asali, ba a amfani da shi don babban gwajin sauri a ƙarƙashin yanayin rashin kayan aiki.
Idan aka kwatanta da gano nucleic acid, hanyoyin gano saurin ganowa na yanzu sun haɗa da gano antigen da gano ƙwayoyin cuta.Binciken antigen yana bincika ko akwai ƙwayoyin cuta a cikin jiki, yayin da maganin rigakafi ke bincika ko jikin ya sami juriya ga ƙwayoyin cuta bayan kamuwa da cuta.
A halin yanzu, gano maganin rigakafi yawanci yana gano ƙwayoyin rigakafin IgM da IgG a cikin maganin ɗan adam.Bayan kwayar cutar ta mamaye jikin dan adam, ana daukar kimanin kwanaki 5-7 kafin a samar da kwayoyin rigakafin IgM, kuma ana samar da rigakafin IgG a cikin kwanaki 10-15.Saboda haka, akwai babban damar ganowa da aka rasa tare da gano maganin rigakafi, kuma mai yiwuwa majinyacin da aka gano ya kamu da mutane da yawa.
Hoto na 1:NEWGENE Kayan Gano Maganin Cutar
Idan aka kwatanta da gano maganin rigakafi, gano antigen na iya gano ƙwayar cuta gabaɗaya a cikin lokacin shiryawa, lokaci mai tsanani ko farkon cutar, kuma baya buƙatar yanayin dakin gwaje-gwaje da ayyukan ƙwararru.Gano Antigen ya dace musamman don yanayin yanayin inda ƙwararrun kayan aikin likita da ƙwararru suka rasa.Yana da matukar mahimmanci ga ganowa da wuri da kuma kula da marasa lafiya da ke fama da cutar ta COVID-19.
Hoto na 2:NEWGENE Antigen Gane Samfur
The Novel Coronavirus Spike Protein Detection Kit wanda NEWGENE ya kirkira kuma ya samar shine ɗayan farkon samfuran gano antigen da aka haɓaka a China.Hukumar Kula da Magunguna da Kula da Lafiya ta Burtaniya (MHRA) ce ta yi rajista, ta sami takardar shedar EU CE, kuma an samu nasarar shigar da ita cikin "jerin izinin fitarwa" na Ma'aikatar Ciniki ta kasar Sin.
Samfurin ba wai kawai yana riƙe fa'idodin saurin ganowa ba, aiki mai sauƙi, ƙarancin farashi, da kwanciyar hankali mai kyau, amma kuma yana haɓaka ƙayyadaddun ganowa da daidaito.A lokaci guda, wannan fasaha tana da amfani sosai wajen gano coronaviruses wanda mai karɓar ACE2 ya shiga tsakani.Ko da kwayar cutar ta sami maye gurbin, za a iya shigar da kayan ganowa cikin sauri ba tare da jiran haɓakar sabbin ƙwayoyin rigakafi ba, wanda ke ba da tallafin fasaha mai mahimmanci don aikin rigakafin cutar nan gaba.
Lokacin aikawa: Afrilu-01-2021